Gliptin-associated bullous pemphigoid exhibits distinct clinical and immunological features according to the specific gliptin used: implications for diagnostic accuracy and personalized patient management

In a large multicenter cohort of 212 gliptin-associated bullous pemphigoid (GABP) patients, we show that linagliptin-associated BP often presents with a distinctive double-negative (DN) serological phenotype (BP180-NC16A/BP230 negative) and is linked to milder disease severity, supporting a less aggressive therapeutic approach in these patients. From a diagnostic standpoint, our data support the use of an assay based on the ectodomain of BP180 in patients who test negative on commercial BP180-NC16A/BP230 ELISAs.

Authors

Institutions

Publication Details

Journal
British Journal of Dermatology
Published
2026-11-19
DOI
https://doi.org/10.1093/bjd/ljag502
Primary Topic
Autoimmune Bullous Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Gliptin-associated bullous pemphigoid exhibits distinct clinical and immunological features according to the specific gliptin used: implications for diagnostic accuracy and personalized patient management

Lidia Francesconi, Angelo Valerio Marzano, Jo Linda Sinagra, Manuela Papini et al.
British Journal of Dermatology
Autoimmune Bullous Skin Diseases
article

Gliptin-associated bullous pemphigoid exhibits distinct clinical and immunological features according to the specific gliptin used: implications for diagnostic accuracy and personalized patient management

Lidia Francesconi, Angelo Valerio Marzano, Jo Linda Sinagra, Manuela Papini, Anna Rita Giampetruzzi, Biagio Didona, Anna Pira, Emanuele Cozzani, Rosanna Rita Satta, Giulia Gasparini, Marzia Ballesio, Adele Salemme, Emiliano Antiga, Feliciana Mariotti, Giovanni Genovese, Marzia Caproni, Dario Didona, Alessandra Scarabello, Alessandra Rallo, Giovanni Di Zenzo, Barbara Bellei, Sabatino Pallotta, Clara De Simone
article en

Abstract

In a large multicenter cohort of 212 gliptin-associated bullous pemphigoid (GABP) patients, we show that linagliptin-associated BP often presents with a distinctive double-negative (DN) serological phenotype (BP180-NC16A/BP230 negative) and is linked to milder disease severity, supporting a less aggressive therapeutic approach in these patients. From a diagnostic standpoint, our data support the use of an assay based on the ectodomain of BP180 in patients who test negative on commercial BP180-NC16A/BP230 ELISAs.

British Journal of Dermatology
Università Cattolica del Sacro Cuore (IT), University of Sassari (IT), University of Milan (IT), University of Perugia (IT), Agostino Gemelli University Polyclinic (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani (IT), Istituto Dermopatico dell'Immacolata (IT), San Gallicano Hospital (IT), Ospedale Policlinico San Martino (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Azienda Usl Toscana Centro (IT), University of Florence (IT)
Autoimmune Bullous Skin Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon